Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Confo Therapeutics

News headline image
Confo Therapeutics Announces Publication in Nature Communications Demonstrating First-Ever Structure of a Complex Between an Antibody-based Agonist and a Class A GPCR Regulating Hunger and Satiety
From Confo Therapeutics
Via Business Wire
News headline image
Confo Therapeutics Announces EUR 60M Series B Financing to Advance Pipeline of Novel GPCR-Modulating Therapies into Clinical Development
From Confo Therapeutics
Via Business Wire
News headline image
Confo Therapeutics Secures VLAIO Grant Supporting Drug Discovery & Development in Endocrine and Metabolic Diseases
From Confo Therapeutics
Via Business Wire
News headline image
Confo Therapeutics Appoints Stephen Dowd as Chief Business Officer
From Confo Therapeutics
Via Business Wire
News headline image
Confo Therapeutics Appoints Dieter Weinand, Former CEO of Bayer Pharmaceuticals, as Independent Chairman
From Confo Therapeutics
Via Business Wire
News headline image
Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera
From Confo Therapeutics
Via Business Wire
News headline image
Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases
From Confo Therapeutics
Via Business Wire
News headline image
Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554
From Confo Therapeutics
Via Business Wire
News headline image
Confo Therapeutics’ Scientific Founder Jan Steyaert Receives Prestigious Gabbay Award for Contributions to Structural Biology
From Confo Therapeutics
Via Business Wire
News headline image
Confo Therapeutics Announces Poster Presentations on CFTX-1554 Preclinical Profiling and Mechanism of Action at the IASP 2022 World Congress on Pain
From Confo Therapeutics
Via Business Wire
News headline image
Confo Therapeutics Awarded EUR 1.7M VLAIO Grant to Expand Application of ConfoBody® Drug Discovery and Development Technology in Rare Diseases
From Confo Therapeutics
Via Business Wire
News headline image
Confo Therapeutics Expands Patent Estate for ConfoBody®-based GPCR Screening Platform
From Confo Therapeutics
Via Business Wire
News headline image
Confo Therapeutics Enters Collaborative Agreement with Regeneron
From Confo Therapeutics
Via Business Wire
News headline image
Confo Therapeutics Establishes Medical Advisory Board
From Confo Therapeutics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.